Class summary at a glance.

Every drug in the First-Generation Antihistamine / Anxiolytic class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $114.8Mcombined across class
Total Rx claims: 7.2M2.5M unique beneficiaries
Generic mfrs (active): 23across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Hydroxyzine

Brand: Hydroxyzine Hydrochloride · 7.2M Part D claims (CY24) · 2.5M beneficiaries · First FDA approval: 1981-12-14

23 generic mfrs 924 plans require PA

Low NADAC$0.031

→

Avg plan cost$0.059

Part D spend $114.8M 2× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.